Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,213 | -3,710 | -2,543 | -11,510 | -7,378 |
| Depreciation Amortization | N/A | N/A | N/A | 1,562 | 1,562 |
| Accounts receivable | N/A | N/A | -20 | N/A | N/A |
| Accounts payable and accrued liabilities | 529 | 113 | 451 | 950 | 540 |
| Other Working Capital | 2,367 | 1,391 | 564 | 2,470 | 1,774 |
| Other Operating Activity | 2,630 | 1,083 | 765 | 2,821 | 446 |
| Operating Cash Flow | $-1,687 | $-1,123 | $-783 | $-3,707 | $-3,056 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 251 | 51 | 46 | 33 | 33 |
| Debt Issued | N/A | 122 | N/A | N/A | 0 |
| Common Stock Issued | 1,146 | 723 | 401 | 3,632 | 2,650 |
| Financing Cash Flow | $1,396 | $896 | $447 | $3,665 | $2,683 |
| Beginning Cash Position | 346 | 346 | 346 | 389 | 389 |
| End Cash Position | 55 | 119 | 10 | 346 | 15 |
| Net Cash Flow | $-291 | $-227 | $-336 | $-43 | $-374 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,687 | -1,123 | -783 | -3,707 | -3,056 |
| Free Cash Flow | -1,687 | -1,123 | -783 | -3,707 | -3,056 |